NL-OMON50008尚未招募不适用
The early stage SARS-CoV-2 immune response including antibody kinetics in out of hospital patients with mild COVID-19 symptoms - Early stage immune responses against SARS-CoV-2
Reade, reumatologie en revalidatie te Amsterdam0 个研究点目标入组 14 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age > 18 years;
- •2. Symptoms associated with a COVID-19 infection;
- •3. Travelled to an endemic region or have contact with a person who is
- •suspected for/or diagnosed with a COVID-19 infection or had a SARS-CoV-2
- •positive PCR;
- •4. Mild COVID-19 symptoms which did not require hospital admittance;
- •5. No more than 10 days between symptoms associated with a COVID-19 infection
- •and the screening visit.
排除标准
- •1. Language problems precluding the completion of the questionnaire or
- •understanding the informed consent;
- •2. Likelihood of absence in the next 4 weeks.
研究者
相似试验
招募中
不适用
SARS-CoV-2 immune responseCOVID-1910047438NL-OMON55057Diakonessenhuis Utrecht800
进行中（未招募）
1 期
SARS-CoV-2 immune responseimmune response to COVDI-19 vaccinationEUCTR2021-001202-30-NLDiakonessenhuis400
已完成
不适用
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
已完成
不适用
Baseline immunity to SARS-CoV-2 (COVID-19) in the German population.COVID19U07.1COVID-19, virus identifiedDRKS00029693Institut für Virologie/Universitätsklinikum Bonn15,941
已完成
4 期
SARS-CoV-2-specific immune responses after two versus three doses COVID-19 vaccination in end-stage renal disease patients and kidney transplant recipientsCOVID-19renal transplant, immunogenicity, safety, humoral immunity, cell-mediated immunityTCTR20210524002Faculty of Medicine Ramathibodi Hospital, Mahidol University120